GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Long-Term Debt

Alto Neuroscience (Alto Neuroscience) Long-Term Debt : $8.81 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Long-Term Debt?

Alto Neuroscience's Long-Term Debt for the quarter that ended in Mar. 2024 was $8.81 Mil.

Alto Neuroscience's quarterly Long-Term Debt increased from Sep. 2023 ($9.76 Mil) to Dec. 2023 ($9.86 Mil) but then declined from Dec. 2023 ($9.86 Mil) to Mar. 2024 ($8.81 Mil).

Alto Neuroscience's annual Long-Term Debt increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($9.47 Mil) and increased from Dec. 2022 ($9.47 Mil) to Dec. 2023 ($9.86 Mil).

Alto Neuroscience Long-Term Debt Historical Data

The historical data trend for Alto Neuroscience's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Long-Term Debt Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Long-Term Debt
- 9.47 9.86

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial 9.47 - 9.76 9.86 8.81

Alto Neuroscience  (NYSE:ANRO) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Alto Neuroscience Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Long-Term Debt
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024